Kansas City, KS6 Active Studies

Cystic Fibrosis Clinical Trials in Kansas City, KS

Find 6 actively recruiting cystic fibrosis clinical trials in Kansas City, KS. Connect with local research sites and explore new treatment options.

6
Active Trials
6
Sponsors
500
Enrolling

Recruiting Cystic Fibrosis Studies in Kansas City

RecruitingKansas City, KSNCT05422222

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at least 1 triple combina...

210 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingKansas City, KSNCT06449677

Bionic Pancreas in CFRD

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using...

150 participants
Jaeb Center for Health Research
View Study Details
RecruitingKansas City, KSNCT05517655

BEGIN Novel ImagiNG Biomarkers

To determine the treatment effect of triple-combination therapy in 6-8 year olds after presumed FDA approval, using rapid structural and functional pulmonary and abdominal MRI (UTE and 129Xe)....

44 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingKansas City, KSNCT06159725

A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

CMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of this clinical trial is to assess the safety and tol...

41 participants
Clarametyx Biosciences, Inc.
View Study Details
RecruitingKansas City, KSNCT05248230

4D-710 in Adult Patients With Cystic Fibrosis

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....

40 participants
4D Molecular Therapeutics
View Study Details
RecruitingKansas City, KSNCT06526923

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy....

15 participants
Spirovant Sciences, Inc.
View Study Details

About Cystic Fibrosis Clinical Trials in Kansas City

Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.

There are currently 6 cystic fibrosis clinical trials recruiting participants in Kansas City, KS. These studies are seeking a combined 500 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, Jaeb Center for Health Research, Children's Hospital Medical Center, Cincinnati and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Cystic Fibrosis Clinical Trials in Kansas City — FAQ

Are there cystic fibrosis clinical trials in Kansas City?

Yes, there are 6 cystic fibrosis clinical trials currently recruiting in Kansas City, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What cystic fibrosis treatments are being tested?

The 6 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.

Data updated March 2, 2026 from ClinicalTrials.gov